Boots Q2 revenue below expectations

Boots Group PLC reported underlying second quarter sales growth at its core Boots chemists chain below market expectations.

BTC (Boots the Chemists) notched-up second quarter to end-September sales growth of 3.0% with a like-for-like increase of 2.9%. This was below sector analysts' forecasts of a rise of 3.5-4.7% and down from growth of 4.6% in the first quarter.